1. Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience. (November 2022) Authors: Caldart, A.; Fiorio, E.; Zanelli, S.; Biondani, P.; Parolin, V.; Pellini, F.; Montemezzi, S.; Nottegar, A.; Caliò, A.; Zampiva, I.; Merler, S.; Mongillo, M.; Avesani, B.; Borghesani, G.; Giontella, E.; Scarpa, A.; Milella, M. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FDG PET/CT and breast cancer: Surgery or neoadjuvant CT?. Issue 4 (April 2018) Authors: Invento, A.; Pellini, F.; Mirandola, S.; Grigolato, D.; Ferdeghini, M.; Pollini, G.P. Journal: European journal of surgical oncology Issue: Volume 44:Issue 4(2018) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Italian Men Tested for BRCA1/2 Mutation: Psychological Distress during 6-Month Follow-Up. (31st January 2020) Authors: Pellini, F.; Mirandola, S.; Granuzzo, E.; Urbani, S.; Piccinni Leopardi, G.; Pollini, G. P. Other Names: Colloca Giuseppe Guest Editor. Journal: Journal of oncology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗